Top

American Journal of Clinical Dermatology

Published in:

01-08-2020 | Panniculitis | Review Article

Dermatologic Sequelae Associated with Radiation Therapy

Authors: Kurt A. Ashack, Victoria Kuritza, Michael J. Visconti, Laura Ashack

Published in: American Journal of Clinical Dermatology | Issue 4/2020

Abstract

Radiation therapy is a mainstay for the treatment of primary malignancies and metastatic disease and is associated with several dermatological adverse events that are underreported in the literature. The objective of this paper was to review the literature regarding cutaneous manifestations associated with radiation therapy in order to promote awareness of the cutaneous radiation therapy-associated adverse effects. This extensive literature review was performed using the Pubmed and Embase databases. Studies were reviewed for relevance and critical evidence pertaining to cutaneous manifestations of radiation therapy. The most commonly reported cutaneous sequelae associated with radiation therapy include radiation dermatitis, non-melanoma skin cancer, radiation-associated angiosarcoma, morphea, bullous pemphigoid, lymphangioma circumscriptum, and pseudosclerodermatous panniculitis. For many of these conditions, only case reports or case series exist and there is an absence of large-scale cohort studies. Despite these limitations, this review describes the wide range of dermatological adverse events associated with radiation therapy.

Goldschmidt H, Breneman JC, Breneman DL. Ionizing radiation therapy in dermatology. J Am Acad Dermatol. 1994;30(2 Pt 1):157–82. https://doi.org/10.1016/s0190-9622(94)70014-1.PubMedCrossRef

Halperin EP. Brady's principles and practice of radiation oncology. South Holland: Wolters Kluwer; 2019.

Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol. 2006;54(1):28–46. https://doi.org/10.1016/j.jaad.2005.08.054.PubMedCrossRef

Hegedus F, Mathew LM, Schwartz RA. Radiation dermatitis: an overview. Int J Dermatol. 2017;56(9):909–14. https://doi.org/10.1111/ijd.13371.PubMedCrossRef

Singh M, Alavi A, Wong R, Akita S. Radiodermatitis: a Review of Our Current Understanding. Am J Clin Dermatol. 2016;17(3):277–92. https://doi.org/10.1007/s40257-016-0186-4.PubMedCrossRef

Hall E, Giaccia A. Radiobiology for the radiologist. South Holland: Wolters Kluwer; 2019.

Mendelsohn FA, Divino CM, Reis ED, Kerstein MD. Wound care after radiation therapy. Adv Skin Wound Care. 2002;15(5):216–24.PubMed

Rosenthal A, Israilevich R, Moy R. Management of acute radiation dermatitis: a review of the literature and proposal for treatment algorithm. J Am Acad Dermatol. 2019;81(2):558–67. https://doi.org/10.1016/j.jaad.2019.02.047.PubMedCrossRef

US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0. 2017. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf. Accessed 27 Mar 2018.

10.

Miller RC, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, et al. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys. 2011;79(5):1460–6. https://doi.org/10.1016/j.ijrobp.2010.01.031.PubMedCrossRef

11.

Ho AY, Olm-Shipman M, Zhang Z, Siu CT, Wilgucki M, Phung A, et al. A randomized trial of mometasone furoate 0.1% to reduce high-grade acute radiation dermatitis in breast cancer patients receiving postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2018;101(2):325–33. https://doi.org/10.1016/j.ijrobp.2018.02.006.PubMedCrossRef

12.

Salvo N, Barnes E, van Draanen J, Stacey E, Mitera G, Breen D, et al. Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Curr Oncol. 2010;17(4):94–112. https://doi.org/10.3747/co.v17i4.493.PubMedPubMedCentralCrossRef

13.

Roy I, Fortin A, Larochelle M. The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol. 2001;58(3):333–9. https://doi.org/10.1016/s0167-8140(00)00322-4.PubMedCrossRef

14.

Campbell IR, Illingworth MH. Can patients wash during radiotherapy to the breast or chest wall? A randomized controlled trial. Clin Oncol (R Coll Radiol). 1992;4(2):78–82. https://doi.org/10.1016/s0936-6555(05)80971-9.CrossRef

15.

Niazi TM, Vuong T, Azoulay L, Marijnen C, Bujko K, Nasr E, et al. Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase III study. Int J Radiat Oncol Biol Phys. 2012;84(3):e305–e310310. https://doi.org/10.1016/j.ijrobp.2012.03.062.PubMedCrossRef

16.

Aquino-Parsons C, Lomas S, Smith K, Hayes J, Lew S, Bates AT, et al. Phase III study of silver leaf nylon dressing vs standard care for reduction of inframammary moist desquamation in patients undergoing adjuvant whole breast radiation therapy. J Med Imaging Radiat Sci. 2010;41(4):215–21. https://doi.org/10.1016/j.jmir.2010.08.005.PubMedCrossRef

17.

Hemati S, Asnaashari O, Sarvizadeh M, Motlagh BN, Akbari M, Tajvidi M, et al. Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer. Support Care Cancer. 2012;20(8):1613–8. https://doi.org/10.1007/s00520-011-1250-5.PubMedCrossRef

18.

Martin M, Lefaix J, Delanian S. TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys. 2000;47(2):277–90. https://doi.org/10.1016/s0360-3016(00)00435-1.PubMedCrossRef

19.

de Andrade CBV, Ramos IPR, de Moraes ACN, do Nascimento ALR, Salata C, Goldenberg R et al. Radiotherapy-induced skin reactions induce fibrosis mediated by TGF-beta1 Cytokine. Dose Response 2017;15(2):1559325817705019. https://doi.org/10.1177/1559325817705019.

20.

Okunieff P, Augustine E, Hicks JE, Cornelison TL, Altemus RM, Naydich BG, et al. Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol. 2004;22(11):2207–13. https://doi.org/10.1200/JCO.2004.09.101.PubMedCrossRef

21.

Delanian S, Balla-Mekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol. 1999;17(10):3283–90. https://doi.org/10.1200/JCO.1999.17.10.3283.PubMedCrossRef

22.

Wong RK, Bensadoun RJ, Boers-Doets CB, Bryce J, Chan A, Epstein JB, et al. Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer. 2013;21(10):2933–48. https://doi.org/10.1007/s00520-013-1896-2.PubMedCrossRef

23.

Spalek M. Chronic radiation-induced dermatitis: challenges and solutions. Clin Cosmet Investig Dermatol. 2016;9:473–82. https://doi.org/10.2147/CCID.S94320.PubMedPubMedCentralCrossRef

24.

Leventhal J, Young MR. Radiation Dermatitis: Recognition, Prevention, And Management. Oncol (Williston Park). 2017;31(12):885–7.

25.

Fernandez Canedo I, Padilla Espana L, Millan-Cayetano JF, Repiso Jimenez JB, Perez Delgado M, de Troya MM. Hyperbaric oxygen therapy: an alternative treatment for radiation-induced cutaneous ulcers. Australas J Dermatol. 2018;59(3):e203–e207207. https://doi.org/10.1111/ajd.12763.PubMedCrossRef

26.

Dormand EL, Banwell PE, Goodacre TE. Radiotherapy and wound healing. Int Wound J. 2005;2(2):112–27. https://doi.org/10.1111/j.1742-4801.2005.00079.x.PubMedCrossRef

27.

Olascoaga A, Vilar-Compte D, Poitevin-Chacon A, Contreras-Ruiz J. Wound healing in radiated skin: pathophysiology and treatment options. Int Wound J. 2008;5(2):246–57. https://doi.org/10.1111/j.1742-481X.2008.00436.x.PubMedCrossRef

28.

Hampson NB, Holm JR, Wreford-Brown CE, Feldmeier J. Prospective assessment of outcomes in 411 patients treated with hyperbaric oxygen for chronic radiation tissue injury. Cancer. 2012;118(15):3860–8. https://doi.org/10.1002/cncr.26637.PubMedCrossRef

29.

Futran ND, Trotti A, Gwede C. Pentoxifylline in the treatment of radiation-related soft tissue injury: preliminary observations. Laryngoscope. 1997;107(3):391–5. https://doi.org/10.1097/00005537-199703000-00022.PubMedCrossRef

30.

Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol. 2003;21(13):2545–50. https://doi.org/10.1200/JCO.2003.06.064.PubMedCrossRef

31.

Kulshrestha S, Chawla R, Singh S, Yadav P, Sharma N, Goel R, et al. Protection of sildenafil citrate hydrogel against radiation-induced skin wounds. Burns. 2019. https://doi.org/10.1016/j.burns.2019.11.020.PubMedCrossRef

32.

Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst. 2001;93(2):96–111. https://doi.org/10.1093/jnci/93.2.96.PubMedCrossRef

33.

Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373(4):307–16. https://doi.org/10.1056/NEJMoa1415340.PubMedPubMedCentralCrossRef

34.

Gross JP, Whelan TJ, Parulekar WR, Chen BE, Rademaker AW, Helenowski IB, et al. Development and validation of a nomogram to predict lymphedema after axillary surgery and radiation therapy in women with breast cancer from the NCIC CTG MA20 randomized trial. Int J Radiat Oncol Biol Phys. 2019;105(1):165–73. https://doi.org/10.1016/j.ijrobp.2019.05.002.PubMedCrossRef

35.

Rockson SG. Lymphedema after breast cancer treatment. N Engl J Med. 2018;379(20):1937–44. https://doi.org/10.1056/NEJMcp1803290.PubMedCrossRef

36.

Perkins JL, Liu Y, Mitby PA, Neglia JP, Hammond S, Stovall M, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2005;23(16):3733–41. https://doi.org/10.1200/jco.2005.06.237.PubMedCrossRef

37.

Watt TC, Inskip PD, Stratton K, Smith SA, Kry SF, Sigurdson AJ, et al. Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2012;104(16):1240–50. https://doi.org/10.1093/jnci/djs298.PubMedPubMedCentralCrossRef

38.

Thorsness SL, Freites-Martinez A, Marchetti MA, Navarrete-Dechent C, Lacouture ME, Tonorezos ES. Nonmelanoma skin cancer in childhood and young adult cancer survivors previously treated with radiotherapy. J Natl Compr Canc Netw. 2019;17(3):237–43. https://doi.org/10.6004/jnccn.2018.7096.PubMedCrossRef

39.

Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102(14):1083–95. https://doi.org/10.1093/jnci/djq238.PubMedPubMedCentralCrossRef

40.

Winaikosol K, Surakunprapha P. Rapidly developed secondary cutaneous squamous cell carcinoma after post-surgical radiation therapy for breast cancer. J Med Assoc Thai. 2016;99(Suppl 5):S173–S176176.PubMed

41.

Yokota T, Roppongi T, Kanno K, Tsutsumi H, Sakamoto I, Fujii T. Radiation-induced squamous cell carcinoma of the chest wall seven years after adjuvant radiotherapy following the surgery of breast cancer: a case report [in Japanese]. Kyobu geka. 2000;53(13):1133–6.PubMed

42.

Szymanski LJ, Sibug Saber ME, Kim JW, Go JL, Zada G, Rao N, et al. Quadruple Neoplasms Following Radiation Therapy For Congenital Bilateral Retinoblastoma. Ocular Oncol Pathol. 2017;4(1):33–7. https://doi.org/10.1159/000477410.CrossRef

43.

Allison JR Jr. Radiation-induced basal-cell carcinoma. J Dermatol Surg Oncol. 1984;10(3):200–3. https://doi.org/10.1111/j.1524-4725.1984.tb01207.x.PubMedCrossRef

44.

Beyeler M, Urosevic M, Pestalozzi B, Dummer R. Successful imiquimod treatment of multiple basal cell carcinomas after radiation therapy for Hodgkin's disease. Eur J Dermatol. 2005;15(1):52–5.PubMed

45.

Stante M, Salvini C, De Giorgi V, Carli P. Multiple synchronous pigmented basal cell carcinomas following radiotherapy for Hodgkin's disease. Int J Dermatol. 2002;41(4):208–11. https://doi.org/10.1046/j.1365-4362.2002.01453.x.PubMedCrossRef

46.

Copas P, Spann CO, Majmudar B, Horowitz IR. Basal cell carcinoma due to radiotherapy for carcinoma of the cervix. South Med J. 1995;88(11):1161–2. https://doi.org/10.1097/00007611-199511000-00018.PubMedCrossRef

47.

Handa Y, Miwa S, Yamada M, Ono H, Suzuki T, Tomita Y. Multiple pigmented basal cell carcinomas arising in the normal-appearing skin after radiotherapy for carcinoma of the cervix. Dermatol Surg. 2003;29(12):1233–5. https://doi.org/10.1111/j.1524-4725.2003.29394.x.PubMedCrossRef

48.

Iwamoto I, Endo M, Kakinuma H, Suzuki H. Multiple basal cell carcinoma developing two years after 60Co irradiation. Eur J Dermatol. 1998;8(3):180–2.PubMed

49.

Marin-Gutzke M, Sanchez-Olaso A, Berenguer B, Gonzalez B, Rodriguez P, De Salamanca JE, et al. Basal cell carcinoma in childhood after radiation therapy: case report and review. Ann Plast Surg. 2004;53(6):593–5. https://doi.org/10.1097/01.sap.0000136972.23991.07.PubMedCrossRef

50.

Garcia-Silva J, Velasco-Benito JA, Pena-Penabad C, Armijo M. Basal cell carcinoma in a girl after cobalt irradiation to the cranium for acute lymphoblastic leukemia: case report and literature review. Pediatr Dermatol. 1996;13(1):54–7. https://doi.org/10.1111/j.1525-1470.1996.tb01190.x.PubMedCrossRef

51.

Torres KE, Ravi V, Kin K, Yi M, Guadagnolo BA, May CD, et al. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Ann Surg Oncol. 2013;20(4):1267–74. https://doi.org/10.1245/s10434-012-2755-y.PubMedCrossRef

52.

Kim MK, Huh SJ, Kim DY, Yang JH, Han J, Ahn YC, et al. Secondary angiosarcoma following irradiation–case report and review of the literature. Radiat Med. 1998;16(1):55–60.PubMed

53.

Ahmad A, Jamieson T, Balsitis M, Diament R. Radiation-induced angiosarcoma of the rectum: a case report and review of literature. Colorectal Dis. 2008;10(8):847–8. https://doi.org/10.1111/j.1463-1318.2008.01488.x.PubMedCrossRef

54.

Mittal S, Goswami C, Kanoria N, Bhattacharya A. Post-irradiation angiosarcoma of bone. J Cancer Res Ther. 2007;3(2):96–9.PubMed

55.

Tardio JC, Najera L, Alemany I, Martin T, Castano A, Perez-Regadera JF. Rectal angiosarcoma after adjuvant chemoradiotherapy for adenocarcinoma of the rectum. J Clin Oncol. 2009;27(27):e116–e11717. https://doi.org/10.1200/JCO.2008.21.1979.PubMedCrossRef

56.

Rao J, Dekoven JG, Beatty JD, Jones G. Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast. J Am Acad Dermatol. 2003;49(3):532–8. https://doi.org/10.1067/s0190-9622(03)00428-6.PubMedCrossRef

57.

Yap J, Chuba PJ, Thomas R, Aref A, Lucas D, Severson RK, et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2002;52(5):1231–7. https://doi.org/10.1016/s0360-3016(01)02799-7.PubMedCrossRef

58.

Li GZ, Fairweather M, Wang J, Orgill DP, Bertagnolli MM, Raut CP. Cutaneous radiation-associated breast angiosarcoma: radicality of surgery impacts survival. Ann Surg. 2017;265(4):814–20. https://doi.org/10.1097/SLA.0000000000001753.PubMedCrossRef

59.

Cahan WG, Woodard HQ, et al. Sarcoma arising in irradiated bone; report of 11 cases. Cancer. 1948;1(1):3–29. https://doi.org/10.1002/1097-0142(194805)1:1%3c3:aid-cncr2820010103%3e3.0.co;2-7.PubMedCrossRef

60.

Wei NJJ, Crowley TP, Ragbir M. Early breast angiosarcoma development after radiotherapy: a cautionary tale. Ann Plast Surg. 2019;83(2):152–3. https://doi.org/10.1097/SAP.0000000000001856.PubMedCrossRef

61.

Tomasini C, Grassi M, Pippione M. Cutaneous angiosarcoma arising in an irradiated breast. Case report and review of the literature. Dermatology. 2004;209(3):208–14. https://doi.org/10.1159/000079891.PubMedCrossRef

62.

Cafiero F, Gipponi M, Peressini A, Queirolo P, Bertoglio S, Comandini D, et al. Radiation-associated angiosarcoma: diagnostic and therapeutic implications: two case reports and a review of the literature. Cancer. 1996;77(12):2496–502. https://doi.org/10.1002/(SICI)1097-0142(19960615)77:12%3c2496:AID-CNCR12%3e3.0.CO;2-N.PubMedCrossRef

63.

Shin YB, Choi WJ, Kim C. Radiation-induced cutaneous angiosarcoma of the abdomen in a patient with cervical cancer: a case report. J Obstet Gynaecol Res. 2019;45(9):1941–3. https://doi.org/10.1111/jog.14034.PubMedCrossRef

64.

Meattini I, Santi R, Scartoni D, Giacomelli I, De Luca CC, Scotti V, et al. Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. Case Rep Oncol Med. 2014;2014:413030. https://doi.org/10.1155/2014/413030.PubMedPubMedCentralCrossRef

65.

Lindford A, Bohling T, Vaalavirta L, Tenhunen M, Jahkola T, Tukiainen E. Surgical management of radiation-associated cutaneous breast angiosarcoma. J Plast Reconstr Aesthet Surg. 2011;64(8):1036–42. https://doi.org/10.1016/j.bjps.2011.02.014.PubMedCrossRef

66.

Tomasello L, Gardin G, Boccardo F. Secondary breast angiosarcoma: lethal response to anti-angiogenic therapy with paclitaxel chemotherapy. A case report. Anticancer Res. 2006;26(6C):4775–7.PubMed

67.

Coffin CM, Vietti TJ, Land VJ, Kraybill WG, Dehner LP. Cutaneous angiosarcoma as a second malignant neoplasm after peripheral primitive neuroectodermal tumor. Med Pediatr Oncol. 1992;20(4):352–6. https://doi.org/10.1002/mpo.2950200418.PubMedCrossRef

68.

de Giorgi V, Santi R, Grazzini M, Papi F, Gori A, Rossari S, et al. Synchronous angiosarcoma, melanoma and morphea of the breast skin 14 years after radiotherapy for mammary carcinoma. Acta Derm Venereol. 2010;90(3):283–6. https://doi.org/10.2340/00015555-0841.PubMedCrossRef

69.

Kiyohara T, Kumakiri M, Kobayashl H, Itoh K, Lao LM, Ohkawara A, et al. Spindle cell angiosarcoma following irradiation therapy for cervical carcinoma. J Cutan Pathol. 2002;29(2):96–100. https://doi.org/10.1034/j.1600-0560.2002.290206.x.PubMedCrossRef

70.

Rubin E, Maddox WA, Mazur MT. Cutaneous angiosarcoma of the breast 7 years after lumpectomy and radiation therapy. Radiology. 1990;174(1):258–60. https://doi.org/10.1148/radiology.174.1.2152984.PubMedCrossRef

71.

Mery CM, George S, Bertagnolli MM, Raut CP. Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival. Cancer. 2009;115(18):4055–63. https://doi.org/10.1002/cncr.24462.PubMedCrossRef

72.

Brenn T, Fletcher CD. Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases. Am J Surg Pathol. 2005;29(8):983–96.PubMed

73.

Requena C, Sendra E, Llombart B, Sanmartin O, Guillen C, Lavernia J, et al. Cutaneous Angiosarcoma: Clinical and Pathology Study of 16 Cases. Actas Dermosifiliogr. 2017;108(5):457–65. https://doi.org/10.1016/j.ad.2017.01.014.PubMedCrossRef

74.

Billings SD, McKenney JK, Folpe AL, Hardacre MC, Weiss SW. Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol. 2004;28(6):781–8. https://doi.org/10.1097/01.pas.0000126055.33916.0b.PubMedCrossRef

75.

Hung J, Hiniker SM, Lucas DR, Griffith KA, McHugh JB, Meirovitz A, et al. Sporadic versus radiation-associated angiosarcoma: a comparative clinicopathologic and molecular analysis of 48 cases. Sarcoma. 2013;2013:798403. https://doi.org/10.1155/2013/798403.PubMedPubMedCentralCrossRef

76.

Morgan EA, Kozono DE, Wang Q, Mery CM, Butrynski JE, Baldini EH, et al. Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Ann Surg Oncol. 2012;19(12):3801–8. https://doi.org/10.1245/s10434-012-2563-4.PubMedCrossRef

77.

Jallali N, James S, Searle A, Ghattaura A, Hayes A, Harris P. Surgical management of radiation-induced angiosarcoma after breast conservation therapy. Am J Surg. 2012;203(2):156–61. https://doi.org/10.1016/j.amjsurg.2010.12.011.PubMedCrossRef

78.

Shah S, Rosa M. Radiation-associated angiosarcoma of the breast: clinical and pathologic features. Arch Pathol Lab Med. 2016;140(5):477–81. https://doi.org/10.5858/arpa.2014-0581-RS.PubMedCrossRef

79.

Deyrup AT, Miettinen M, North PE, Khoury JD, Tighiouart M, Spunt SL, et al. Pediatric cutaneous angiosarcomas: a clinicopathologic study of 10 cases. Am J Surg Pathol. 2011;35(1):70–5. https://doi.org/10.1097/PAS.0b013e3181ffd9d5.PubMedCrossRef

80.

Fodor J, Orosz Z, Szabo E, Sulyok Z, Polgar C, Zaka Z, et al. Angiosarcoma after conservation treatment for breast carcinoma: our experience and a review of the literature. J Am Acad Dermatol. 2006;54(3):499–504. https://doi.org/10.1016/j.jaad.2005.10.017.PubMedCrossRef

81.

Sholl LM, Barletta JA, Hornick JL. Radiation-associated neoplasia: clinical, pathological and genomic correlates. Histopathology. 2017;70(1):70–80. https://doi.org/10.1111/his.13069.PubMedCrossRef

82.

Friedman O, Barnea Y, Hafner A. Underdiagnosed and disfiguring: radiation-induced morphea following breast cancer treatment. Breast. 2018;39:97–100. https://doi.org/10.1016/j.breast.2018.04.006.PubMedCrossRef

83.

Afonso-Afonso FJ, Arevalo MP, Cerecedo FC, De Paz AL, Tonder CD. Post-irradiation morphea in breast cancer: an uncommon differential diagnosis to keep in Mind. World J Oncol. 2010;1(6):250–1. https://doi.org/10.4021/wjon264w.PubMedCrossRef

84.

Bleasel NR, Stapleton KM, Commens C, Ahern VA. Radiation-induced localized scleroderma in breast cancer patients. Australas J Dermatol. 1999;40(2):99–102.PubMed

85.

Peterson LS, Nelson AM, Su WP, Mason T, O'Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960–1993. J Rheumatol. 1997;24(1):73–80.PubMed

86.

Mittal A, Mittal V, Panse G, Choi JN, Kwong BY, Leventhal JS. Radiation-induced morphea: Association with autoimmune comorbidities, severity, and response to therapy. J Am Acad Dermatol. 2019;81(1):260–2. https://doi.org/10.1016/j.jaad.2019.02.039.PubMedCrossRef

87.

Davis DA, Cohen PR, McNeese MD, Duvic M. Localized scleroderma in breast cancer patients treated with supervoltage external beam radiation: radiation port scleroderma. J Am Acad Dermatol. 1996;35(6):923–7. https://doi.org/10.1016/s0190-9622(96)90116-4.PubMedCrossRef

88.

Schaffer JV, Carroll C, Dvoretsky I, Huether MJ, Girardi M. Postirradiation morphea of the breast presentation of two cases and review of the literature. Dermatology. 2000;200(1):67–71. https://doi.org/10.1159/000018322.PubMedCrossRef

89.

Spalek M, Jonska-Gmyrek J, Galecki J. Radiation-induced morphea: a literature review. J Eur Acad Dermatol Venereol. 2015;29(2):197–202. https://doi.org/10.1111/jdv.12704.PubMedCrossRef

90.

Thomas RM, Worswick S, Aleshin M. Retinoic acid for treatment of systemic sclerosis and morphea: a literature review. Dermatol Ther. 2017;30:2. https://doi.org/10.1111/dth.12455.CrossRef

91.

Reddy SM, Pui JC, Gold LI, Mitnick HJ. Postirradiation morphea and subcutaneous polyarteritis nodosa: case report and literature review. Semin Arthritis Rheum. 2005;34(5):728–34. https://doi.org/10.1016/j.semarthrit.2004.11.004.PubMedCrossRef

92.

Morganroth PA, Dehoratius D, Curry H, Elenitsas R. Postirradiation morphea: a case report with a review of the literature and summary of the clinicopathologic differential diagnosis. Am J Dermatopathol. 2013. https://doi.org/10.1097/DAD.0b013e3181cb3fdd.PubMedCrossRef

93.

Trivedi A, DeWitt CM, McGevna L. Radiation-induced circumscribed superficial morphea after brachytherapy for endometrial adenocarcinoma. Int J Womens Dermatol. 2017;3(4):234–6. https://doi.org/10.1016/j.ijwd.2017.09.002.PubMedPubMedCentralCrossRef

94.

Nguyen T, Kwan JM, Ahmed AR. Relationship between radiation therapy and bullous pemphigoid. Dermatology. 2014;229(2):88–96. https://doi.org/10.1159/000362208.PubMedCrossRef

95.

Hung TL, Chen YL, Lin KT, Chiang CP, Chung CH, Hung CT, et al. Risk of radiotherapy-associated autoimmune bullous disease among Taiwanese patients with breast cancer: a case-control study. Arch Dermatol Res. 2020;312(1):69–75. https://doi.org/10.1007/s00403-019-01985-y.PubMedCrossRef

96.

Duschet P, Schwarz T, Gschnait F. Bullous pemphigoid after radiation therapy. J Am Acad Dermatol. 1988;18(2 Pt 2):441–4. https://doi.org/10.1016/s0190-9622(88)70066-3.PubMedCrossRef

97.

Mul VE, van Geest AJ, Pijls-Johannesma MC, Theys J, Verschueren TA, Jager JJ, et al. Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect. Radiother Oncol. 2007;82(1):5–9. https://doi.org/10.1016/j.radonc.2006.11.014.PubMedCrossRef

98.

Kluger N, Mandelin J, Santti K, Jeskanen L, Nuutinen P. Bullous pemphigoid triggered by radiotherapy for breast cancer. Presse Med. 2017;46(1):128–30. https://doi.org/10.1016/j.lpm.2016.09.019.PubMedCrossRef

99.

Bernhardt M. Bullous pemphigoid after irradiation therapy. J Am Acad Dermatol. 1989;20(1):141–2. https://doi.org/10.1016/s0190-9622(89)80020-9.PubMedCrossRef

100.

Holler U, Schubert T, Budach V, Trefzer U, Beyer M. Blisters—an unusual effect during radiotherapy. Strahlenther Onkol. 2013;189(11):977–9. https://doi.org/10.1007/s00066-013-0444-9.PubMedCrossRef

101.

Jappe U, Bonnekoh B, Gollnick H. Guess what! Initially localized bullous pemphigoid at the irradiation site of breast carcinoma. Eur J Dermatol. 1999;9(2):139–41.PubMed

102.

Neve S, Eppinga WS. A woman with blister formation after radiotherapy [in Dutch]. Ned Tijdschr Geneeskd. 2010;154:A807.PubMed

103.

Furukawa F, Ozaki M, Imamura S, Hirose S. Bullous pemphigoid associated with radiotherapy for esophageal carcinoma. Dermatologica. 1981;162(6):451–4. https://doi.org/10.1159/000250316.PubMedCrossRef

104.

Knoell KA, Patterson JW, Gampper TJ, Hendrix JD Jr. Localized bullous pemphigoid following radiotherapy for breast carcinoma. Arch Dermatol. 1998;134(4):514–5. https://doi.org/10.1001/archderm.134.4.514.PubMedCrossRef

105.

Cliff S, Harland CC. Bullous pemphigoid following radiotherapy. Clin Exp Dermatol. 1995;20(4):360–1. https://doi.org/10.1111/j.1365-2230.1995.tb01348.x.PubMedCrossRef

106.

Cliff S, Harland CC, Fallowfield ME, Mortimer PS. Localised bullous pemphigoid following radiotherapy. Acta Derm Venereol. 1996;76(4):330–1. https://doi.org/10.2340/0001555576330331.PubMedCrossRef

107.

Delaporte E, Nicolas J, Piette F, Bergoend H. Bullous pemphigoid following radiotherapy. Clin Exp Dermatol. 1995;20(4):361. https://doi.org/10.1111/j.1365-2230.1995.tb01349.x.PubMedCrossRef

108.

Zhou X, Velez NF, Farsani T, Tsiaras W, Laga AC, Werchniak AE, et al. Multiple tense bullae localized to the right breast in a woman in her seventies. JAMA Dermatol. 2013;149(12):1427–8. https://doi.org/10.1001/jamadermatol.2013.4704.PubMedCrossRef

109.

Honl BA, Elston DM. Autoimmune bullous eruption localized to a breast reconstruction site: response to niacinamide. Cutis. 1998;62(2):85–6.PubMed

110.

Laimer M, Nischler E, Anderhuber K, Lanschutzer CM, Hintner H. Unilateral localized bullous pemphigoid following radiotherapy [in German]. Hautarzt. 2009;60(6):494–7. https://doi.org/10.1007/s00105-008-1655-3.PubMedCrossRef

111.

Sears A, Wee JS, Misch K, Natkunarajah J. Bullous pemphigoid induced by radiotherapy recurring on rechallenge. Clin Exp Dermatol. 2012;37(8):916–7. https://doi.org/10.1111/j.1365-2230.2012.04402.x.PubMedCrossRef

112.

Olsha O, Lijoretzky G, Grenader T. Bullous pemphigoid following adjuvant radiotherapy for breast cancer. Breast J. 2011;17(2):204–5. https://doi.org/10.1111/j.1524-4741.2010.01060.x.PubMedCrossRef

113.

Mul VE, Verschueren TA, van Geest AJ, Baumert BG. Bullous pemphigoid (BP) induced by radiotherapy. Radiother Oncol. 2007;82(1):105. https://doi.org/10.1016/j.radonc.2006.11.013.PubMedCrossRef

114.

Calikoglu E, Anadolu R, Erdem C, Calikoglu T. Localized bullous pemphigoid as an unusual complication of radiation therapy. J Eur Acad Dermatol Venereol. 2002;16(6):646–7. https://doi.org/10.1046/j.1468-3083.2002.00653_7.x.PubMedCrossRef

115.

Ohata C, Shirabe H, Takagi K, Kawatsu T, Hashimoto T. Localized bullous pemphigoid after radiation therapy: two cases. Acta Derm Venereol. 1997;77(2):157. https://doi.org/10.2340/0001555577157.PubMedCrossRef

116.

Sheerin N, Bourke JF, Holder J, North J, Burns DA. Bullous pemphigoid following radiotherapy. Clin Exp Dermatol. 1995;20(1):80–2. https://doi.org/10.1111/j.1365-2230.1995.tb01293.x.PubMedCrossRef

117.

Melani L, Giomi B, Antiga E, Torchia D, Caproni M, Fabbri P. Radiation therapy as a trigger factor for initially localized bullous pemphigoid. Breast J. 2005;11(6):485–6. https://doi.org/10.1111/j.1075-122X.2005.00150.x.PubMedCrossRef

118.

Cabrera-Rodriguez JJ, Munoz-Garcia JL, Quiros Rivero J, Ropero Carmona F, Rios KY. Radio-induced bullous pemphigoid. Clin Transl Oncol. 2010;12(1):66–8. https://doi.org/10.1007/s12094-010-0469-9.PubMedCrossRef

119.

Clayton AS, Angeloni V. Bullous pemphigoid in a previously irradiated site. Cutis. 1998;61(2):73–6.PubMed

120.

Isohashi F, Konishi K, Umegaki N, Tanei T, Koizumi M, Yoshioka Y. A case of bullous pemphigoid exacerbated by irradiation after breast conservative radiotherapy. Jpn J Clin Oncol. 2011;41(6):811–3. https://doi.org/10.1093/jjco/hyr049.PubMedCrossRef

121.

Parikh SK, Ravi A, Kuo DY, Nori D. Bullous pemphigoid masquerading as acute radiation dermatitis: case report. Eur J Gynaecol Oncol. 2001;22(5):322–4.PubMed

122.

Folliero G, Zurlo A, Amanti C, Tombolini V, Di Paola M. Bullous pemphigoid induced by radiation therapy. Clin Oncol (R Coll Radiol). 1995;7(4):266–7. https://doi.org/10.1016/s0936-6555(05)80618-1.CrossRef

123.

Binitha MP, Vishnu VV, Sreekanth S, Reena Mariyath OK. Localized bullous pemphigoid on sites of radiotherapy and lymphedema in the same patient. Indian Dermatol Online J. 2014;5(Suppl 2):S101–S103103. https://doi.org/10.4103/2229-5178.146170.PubMedPubMedCentralCrossRef

124.

Campa M, Mansouri B, Wilcox B, Griffin JR. Radiation-induced localized bullous pemphigoid in a patient with breast carcinoma. Dermatol Online J. 2016;22:1.

125.

Srifi N, Benomar S, Zaghba N, Qasmi S, Senouci K, Elgueddari B, et al. Generalized bullous pemphigoid induced by radiotherapy [in French]. Ann Dermatol Venereol. 2011;138(4):311–4. https://doi.org/10.1016/j.annder.2010.11.016.PubMedCrossRef

126.

Rao AG. Acquired lymphangiectasis following surgery and radiotherapy of breast cancer. Indian J Dermatol. 2015;60(1):106. https://doi.org/10.4103/0019-5154.147880.PubMedPubMedCentralCrossRef

127.

Jappe U, Zimmermann T, Kahle B, Petzoldt D. Lymphangioma circumscriptum of the vulva following surgical and radiological therapy of cervical cancer. Sex Transm Dis. 2002;29(9):533–5.PubMed

128.

Chiyomaru K, Nishigori C. Acquired lymphangiectasia associated with treatment for preceding malignant neoplasm: a retrospective series of 73 Japanese patients. Arch Dermatol. 2009;145(7):841–2. https://doi.org/10.1001/archdermatol.2009.124.PubMedCrossRef

129.

Giannelli V, Rockley PF. Acquired lymphangiectasis following mastectomy and radiation therapy: report of a case and review of the literature. Cutis. 1996;58(4):276–8.PubMed

130.

Leshin B, Whitaker DC, Foucar E. Lymphangioma circumscriptum following mastectomy and radiation therapy. J Am Acad Dermatol. 1986;15(5 Pt 2):1117–9. https://doi.org/10.1016/s0190-9622(86)70276-4.PubMedCrossRef

131.

Chang MB, Newman CC, Davis MD, Lehman JS. Acquired lymphangiectasia (lymphangioma circumscriptum) of the vulva: clinicopathologic study of 11 patients from a single institution and 67 from the literature. Int J Dermatol. 2016;55(9):e482–e487487. https://doi.org/10.1111/ijd.13264.PubMedCrossRef

132.

Khunger N. Combination technique of radiofrequency ablation with sclerotherapy in acquired lymphangiectasis of the vulva. J Cutan Aesthet Surg. 2009;2(1):33–5. https://doi.org/10.4103/0974-2077.53098.PubMedPubMedCentralCrossRef

133.

Prioleau PG, Santa Cruz DJ. Lymphangioma circumscriptum following radical mastectomy and radiation therapy. Cancer. 1978;42(4):1989–91. https://doi.org/10.1002/1097-0142(197810)42:4%3c1989:aid-cncr2820420444%3e3.0.co;2-7.PubMedCrossRef

134.

Tulasi NR, John A, Chauhan I, Nagarajan V, Geetha G. Lymphangioma circumscriptum. Int J Gynecol Cancer. 2004;14(3):564–6. https://doi.org/10.1111/j.1048-891x.2004.014323.x.PubMedCrossRef

135.

Gnanaraj P, Revathy V, Venugopal V, Tamilchelvan D, Rajagopalan V. Secondary lymphangioma of vulva: a report of two cases. Indian J Dermatol. 2012;57(2):149–51. https://doi.org/10.4103/0019-5154.94293.PubMedPubMedCentralCrossRef

136.

Schulz D, Lein A, Nicula AP, Schierle K, Solovan C. Lymphangioma circumscriptum post radiotherapy for penile cancer treated with CO(2) laser. Acta Dermatovenerol Croat. 2018;26(1):53–7.PubMed

137.

Winkelmann RK, Grado GL, Quimby SR, Connolly SM. Pseudosclerodermatous panniculitis after irradiation: an unusual complication of megavoltage treatment of breast carcinoma. Mayo Clin Proc. 1993;68(2):122–7. https://doi.org/10.1016/s0025-6196(12)60158-x.PubMedCrossRef

138.

Shirsat HS, Walsh NM, McDonald LJ, Rutledge R, Porter G, Barnes PJ. Postirradiation pseudosclerodermatous panniculitis with involvement of breast parenchyma: a dramatic example of a rare entity and a pitfall in diagnosis. J Cutan Pathol. 2016;43(5):444–50. https://doi.org/10.1111/cup.12683.PubMedCrossRef

139.

Garrido PM, Fernandes I, Pina MF, Soares-Almeida L, Filipe P, Borges-Costa J. Postirradiation pseudosclerodermatous panniculitis mimicking a Kaposi sarcoma recurrence. Int J Dermatol. 2019;58(12):e249–e250250. https://doi.org/10.1111/ijd.14593.PubMedCrossRef

140.

Carrasco L, Moreno C, Pastor MA, Izquierdo MJ, Farina C, Martin L, et al. Postirradiation pseudosclerodermatous panniculitis. Am J Dermatopathol. 2001;23(4):283–7. https://doi.org/10.1097/00000372-200108000-00001.PubMedCrossRef

141.

Sandoval M, Giesen L, Cataldo K, Gonzalez S. Postirradiation pseudosclerodermatous panniculitis of the leg: report of a case and review of the literature. Am J Dermatopathol. 2015;37(7):587–9. https://doi.org/10.1097/DAD.0000000000000139.PubMedCrossRef

142.

Pielasinski U, Machan S, Camacho D, Juarez A, Cedeno M, Macia JA, et al. Postirradiation pseudosclerodermatous panniculitis: three new cases with additional histopathologic features supporting the radiotherapy etiology. Am J Dermatopathol. 2013;35(1):129–34. https://doi.org/10.1097/DAD.0b013e318266b5c7.PubMedCrossRef

143.

Dalle S, Skowron F, Ronger-Savle S, Balme B, Thomas L. Pseudosclerodermatous panniculitis after irradiation and bronchiolitis obliterans organizing pneumonia: simultaneous onset suggesting a common origin. Dermatology. 2004;209(2):138–41. https://doi.org/10.1159/000079599.PubMedCrossRef

144.

Requena L, Ferrandiz C. Sclerosing postirradiation panniculitis. Dermatol Clin. 2008;26(4):505–8. https://doi.org/10.1016/j.det.2008.05.012.PubMedCrossRef

145.

Shon W, Wada DA, Kalaaji AN. Radiation-induced pemphigus or pemphigoid disease in 3 patients with distinct underlying malignancies. Cutis. 2016;97(3):219–22.PubMed

146.

Kose R, Coban YK, Ciralik H. Eccrine porocarcinoma arising from preexisting eccrine poroma of the scalp after radiotherapy for cervical cancer. Dermatol Online J. 2006;12(6):18.PubMed

147.

Pan Z, Bland KI, Wei S. Composite cutaneous atypical vascular lesion and Langerhans cell histiocytosis after radiation for breast carcinoma: can radiation induce Langerhans cell histiocytosis? Dermatol Online J. 2011;17(12):6.PubMed

148.

Kim JH, Krivda SJ. Lichen planus confined to a radiation therapy site. J Am Acad Dermatol. 2002;46(4):604–5. https://doi.org/10.1067/mjd.2002.119654.PubMedCrossRef

149.

Antley CA, Carney M, Smoller BR. Microcystic adnexal carcinoma arising in the setting of previous radiation therapy. J Cutan Pathol. 1999;26(1):48–50. https://doi.org/10.1111/j.1600-0560.1999.tb01790.x.PubMedCrossRef

150.

Beer KT, Buhler SS, Mullis P, Laeng RH, Greiner R. A microcystic adnexal carcinoma in the auditory canal 15 years after radiotherapy of a 12-year-old boy with nasopharynx carcinoma. Strahlenther Onkol. 2005;181(6):405–10. https://doi.org/10.1007/s00066-005-1323-9.PubMedCrossRef

151.

Cohen PR, Maor MH. Tinea corporis confined to irradiated skin Radiation port dermatophytosis. Cancer. 1992;70(6):1634–7. https://doi.org/10.1002/1097-0142(19920915)70:6%3c1634:aid-cncr2820700632%3e3.0.co;2-5.PubMedCrossRef

152.

Chodkiewicz HM, Cohen PR. Radiation port erythema multiforme: erythema multiforme localized to the radiation port in a patient with non-small cell lung cancer. Skinmed. 2012;10(6):390–2.PubMed

153.

Cohen PR, Prieto VG. Radiation port xanthogranuloma: solitary xanthogranuloma occurring within the irradiated skin of a breast cancer patient-report and review of cutaneous neoplasms developing at the site of radiotherapy. J Cutan Pathol. 2010;37(8):891–4. https://doi.org/10.1111/j.1600-0560.2010.01524.x.PubMedCrossRef

154.

Easwaralingam N, Wu Y, Cheung D, Tiver K, Fuller S, Edirimanne S. Radiotherapy for breast cancer associated with a cutaneous presentation of systemic mastocytosis-a case report and literature review. J Surg Case Rep. 2018;2018(11):rjy317. https://doi.org/10.1093/jscr/rjy317.PubMedPubMedCentralCrossRef

Title: Dermatologic Sequelae Associated with Radiation Therapy
Authors: Kurt A. Ashack
Victoria Kuritza
Michael J. Visconti
Laura Ashack
Publication date: 01-08-2020
Publisher: Springer International Publishing
Keywords: Panniculitis
Basalioma
Bullous Pemphigoid
Panniculitis
Lymphedema
Basalioma
Basalioma
Basalioma
Skin Cancer
Published in: American Journal of Clinical Dermatology / Issue 4/2020
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI: https://doi.org/10.1007/s40257-020-00519-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Dermatologic Sequelae Associated with Radiation Therapy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2020

New and Emerging Biologics for Atopic Dermatitis

Treatment Goals in Psoriasis: Which Outcomes Matter Most?

Long-Term Outcomes in BRAF-Mutated Melanoma Treated with Combined Targeted Therapy or Immune Checkpoint Blockade: Are We Approaching a True Cure?

Safety and Effectiveness of Anti-Tumor Necrosis Factor-Alpha Biosimilar Agents in the Treatment of Psoriasis

A Review of Noninvasive Techniques for Skin Cancer Detection in Dermatology

Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis